America’s First IVF Baby Calls for Protections After Alabama Supreme Court Ruling
Elizabeth Carr, 42, is fighting for the treatment that now accounts for some 2% of U.S. births annually
Elizabeth Carr, 42, is fighting for the treatment that now accounts for some 2% of U.S. births annually
Carr leads public relations and patient advocacy at Genomic Prediction, which sells genetic tests to screen embryos. Doctors can order the controversial tests for patients who want to screen for diseases and abnormalities or get an overall embryo health score.
Patients and doctors can use the results to decide which embryos to transfer. Unused embryos can be stored for years. Some get discarded.
For years, genetic tests allowed people who knew they carried genes for lethal diseases to choose embryos that didn’t have them. Genomic Prediction also sells a test to predict a future child’s risk of heart disease, schizophrenia, cancers and diabetes.
IVF doctors disagree over whether the benefit of the tests has been proven.
Photo Editor:
Chase Gaewski
Produced by
Brian Patrick Byrne